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Background: We aimed to examine the course of depression during 2-year follow-up in a group clinically depressed
older persons. Subsequently, we studied which socio-demographic and clinical characteristics predict a depression
diagnoses at 2-year follow-up.
Methods: Data were used from the Netherlands Study of Depression in Older persons (NESDO; N = 510). Diagnoses of
depression DSM-IV-TR criteria were available from 285 patients at baseline and at 2-year follow-up. Severity of the
depressive symptoms, as assessed with the Inventory of Depressive Symptoms (IDS), was obtained from 6-monthly
postal questionnaires. Information about socio-demographic and clinical variables was obtained from the baseline
measurement.
Result: From the 285 older persons who were clinically depressed at baseline almost half (48.4%) also suffered from a
depressive disorder two years later. Patients with more severe depressive symptoms, comorbid dysthymia, younger age
of onset and more chronic diseases were more likely to be depressed at 2-year follow-up. 61% of the persons that were
depressed at baseline had a chronic course of depressive symptoms during these two years.
Conclusions: Late-life depression often has a chronic course, even when treated conform current guidelines for older
persons. Our results suggest that physical comorbidity may be candidate for adjusted and intensified treatment
strategies of older depressed patients with chronic and complex pathology.
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Late-life depression is a complex mood disorder with
various etiological pathways [1] and high comorbidity
with psychiatric and physical diseases, and cognitive de-
cline [2-5]. Late-life depression often has a chronic
course and high relapse rates [6-15], probably worse
compared to younger age groups [16]. Previous studies
were predominantly performed in community based or
primary care samples, and some of them were targeting
depressive symptoms or sub threshold depression, and
not depression diagnoses according to formal diagnostic* Correspondence: h.comijs@ggzingeest.nl
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unless otherwise stated.criteria. However, Beekman et al. [6] showed a gradient
with respect to the prognosis of late-life depression, in
which those with sub threshold disorders had the best
outcome, followed by those with major depressive dis-
order (MDD), dysthymia and double depression (MDD
and dysthymia). Only a few studies investigated the nat-
uralistic course of late-life-depression in a large sample
of older persons with formal depression diagnoses.
Magnil et al. [15] observed the two-year course of depres-
sion in a cohort of primary care patients aged 60 years
and older and found that, 15 of the 51 depressed patients
(29%) had a remitting course, 25 (49%) remained depres-
sive, and 11 (22%) had a fluctuating course. Hybels et al.
[13] were the first to study the course of severe depression
in older patients. They found that it took patients with a
double depression longer to reach partial or full remission,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Depression Rating Scale) scores after 3 years, compared to
those with major depression alone. So, the results suggest
that the course of late-life depression in patients from
mental health institutions may be as poor as in patients
from general practitioners or community based samples.
However, more studies among clinically depressed pa-
tients are necessary to confirm this assumption.
For a better scientific and clinical understanding of the
poor prognosis of late-life depression, it is important to
study the clinical determinants of its course. This may
help us to improve the treatment of late-life depression
and to develop tailor made interventions. Among youn-
ger adults, clinical characteristics of the depression such
as the severity of the depressive disorder, comorbid anx-
iety symptoms and age of onset are consistently found
to be important predictors of the course [16-18]. In-
creased time to recovery from late-life depression is pre-
viously found to be associated with severity of depressive
symptoms [19], but also with chronicity, later age of on-
set, cognitive decline [19,20] and medical comorbidity
[21]. To date there are few longitudinal studies that in-
cluded sufficient numbers of clinically depressed older
persons enabling to study the course and determinants
of the course of late-life depression. In the Netherlands
Study on Depression in Older Persons (NESDO) depressed
patients were included from both mental health care facil-
ities and general practitioners, thus including depressed pa-
tients in various developmental and severity stages [22].
We now have 2-year follow-up data available, which offers
us the possibility to study the two-year course of late-life
depression and its determinants in our cohort.
The aims of the present study were twofold. First, we ex-
amined the course of depression during 2-year follow-up
in a sample of clinically depressed patients, and second we
studied which socio-demographic and clinical characteris-
tics predicted a depression diagnoses at 2-year follow-up.
Based on the literature we expected to find a high percent-
age of persons that are also depressed after 2-year, and that
the severity of the depression and physical comorbidity
would be important determinants of the poor outcome.
Methods
Participants
The Netherlands Study of Depression in Older persons
(NESDO) is an ongoing multi-site cohort study designed to
examine the (determinants of the) course and consequences
of depressive disorders in older persons (≥60 years). Detailed
description of the design and study sample is given in
Comijs et al. [22]. In short, NESDO included 378 depressed
patients (having MDD, dysthymia or minor depression ac-
cording to DSM-IV criteria) and 132 non-depressed adults,
aged 60 through 93 years. Participants were recruited in five
regions in the Netherlands from both mental health carefacilities and general practitioners. Participants were ex-
cluded when they had a dementia diagnosis or were sus-
pected for dementia based on clinician’s judgement. In
addition, to be sure that participants were able to fully
understand and answer the questions, they were only in-
cluded when they had a Mini Mental State Examination-
score (MMSE) [23] of 18 or higher (out of 30 points), and
when they had sufficient command of the Dutch language.
The response rate of the depressed persons from the mental
health institutions was estimated 48.7%, and from the gen-
eral practices 60.3% [22]. Non-depressed comparisons were
recruited from general practitioners (response rate 66.7%),
and were included when they had no lifetime diagnosis of
depression, dementia or other serious psychiatric disorders,
and good command of the Dutch language [22]. The overall
sample of 510 persons had a mean age of 70.6 years (SD:
7.3; range 60–93) and consisted of 331 (64.9%) women and
179 (35.1%) men. The mean level of education was 11.0 years
(SD = 3.6; range 5–18 years). The majority of the sample
had the Dutch nationality (99.4%). The depressed persons
did not differ from the non-depressed comparison group
with respect to mean age and sex, but they had a lower level
of education, were more often divorced or widowed, and
had a lower score on the MMSE [22].
Materials and procedure
Data collection
Data collection of the baseline NESDO measurement
started in 2007 and was finished in September 2010. It
included an extensive assessment of psychopathology,
socio-demographic characteristics, physical health and
physical health markers, cognitive functioning, psycho-
social functioning, and life style variables. The course of
late-life depression was followed up every 6 months by
means of a postal assessment, including questionnaires
on the severity of depressive symptoms and physical
health in the past 6 months, incident (chronic) stressors
and functional limitations, and use of medications and
health care. The questionnaires were the same question-
naires that were used during the face-to-face assessments
[22]. A second face-to-face assessment was performed
2 years after the baseline assessment. It started in 2009
and was completed in September 2012. It consisted of all
baseline measures (determinants and outcome variables)
that were open to change, such as severity of psychopath-
ology and diagnostics. Well-trained research assistants,
mainly consisting of psychologists and mental health care
nurses, conducted the interviews. All interviews were
audio taped and were regularly controlled for their quality.
Ethical issues
The study protocol of NESDO has been approved cen-
trally by the Ethical Review Board of the VU University
Medical Center, and subsequently by the local ethical
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University Medical Center Groningen and the Radboud
University Medical Center in Nijmegen. Written informed
consent was obtained from all participants at the start of
the baseline assessment. Written informed consent was
asked for participating in the study, for permission to use
genetic information, to retrieve medical information from
the GP’s, and to link information to external databases. A
privacy protocol has been developed in which confidenti-
ality of data is guaranteed by using a unique research ID
number for each respondent, which enables to identify in-
dividuals without using their names. Only the data man-
ager has access to the record that links the ID number
with the name of the participant [22]. All data are avail-
able on request (see http://nesdo.amstad.nl/).
Course of depression
Diagnoses of major depression, dysthymia and minor de-
pression according to DSM-IV-TR criteria [24] at base-
line and at two-year follow-up were assessed with the
Composite International Diagnostic Interview (CIDI; WHO
version 2.1). The CIDI is a structured clinical interview that
is designed for use in research settings and has high validity
for depressive and anxiety disorders [25,26]. Questions were
added to determine the DSM-IV research diagnosis of
current minor depression [22].
More detailed information about the severity of the
depressive symptoms was obtained from the postal ques-
tionnaires, that were send to the respondents every
6 months. Severity of the depressive symptoms was
assessed with the Inventory of Depressive Symptoms
(IDS) [27]. The IDS is a 30-item self-report scale that
was developed to carefully assess all core criterion
diagnostic depressive symptoms. The scale has accept-
able psychometric properties in depressed outpatients
e.g. [27,28] and depressed inpatients [29]. The IDS is
sensitive to both change over time and to differences
between treatment conditions [30]. Chronbach’s alpha
for the IDS in our sample was 0.83. The IDS was also
included in the baseline and 2-year follow-up assess-
ment, resulting in a total of 5 IDS ratings per partici-
pant. The IDS-scores range between 0 and 84, and is
categorized according to severity as; < 14: no depres-
sion, 14–25: mild depression, 26 – 38 moderate depression,
39–48: severe depression and ≥ 49: very severe depression.
Course types of depressive symptoms were computed from
patients from whom we had at least 4 out of 5 IDS scores.
We distinguished 5 course types:
1. remission, defined as at least the last two
observations IDS score < 14,
2. intermittent depression, defined as at least one of
the observations IDS < 14 (not being the last two
observations),3. chronic depression, defined as all IDS scores > 14
and 38 and sub classified as:
a. chronic mild to moderate depression, defined as
all IDS scores between 14 and 26,
b. chronic moderate to severe depression, defined as
all IDS scores between 26 and 84,
c. chronic depression with variable severity, defined
as IDS scores varying between 14 to 84.
Determinants of depressive disorder at 2-year follow-up
Socio-demographic characteristics including age, sex, years
of education, and partner status were assessed with stand-
ard questions. Sampling characteristics included sampling
site (Amsterdam, Leiden, Groningen, Apeldoorn/Zutphen
and Nijmegen) and sampling frame (primary care, ambu-
lant health care and clinical health care).
Clinical variables included; first episode MDD (y/n),
comorbid dysthymia (y/n), age of onset, comorbid anx-
iety disorder(s) (y/n), severity of depressive symptoms,
cognitive functioning and number of chronic diseases.
Information about the first episode MDD, recurrent
MMD, dysthymia, and age of onset were all obtained
from the CIDI (WHO version 2.1). Comorbid anxiety
disorders (General Anxiety Disorder, Panic Disorder,
Agoraphobia and Social Phobia) were also assessed
using the CIDI. The Mini-Mental State Examination
(MMSE) [23] was used to assess global cognitive func-
tioning. The presence of chronic diseases was assessed
by means of a self-report questionnaire. The partici-
pants were asked whether they currently or previously
had any of the following chronic diseases or disease
events: cardiac disease (including myocardial infarction),
peripheral atherosclerosis, stroke, diabetes mellitus, COPD
(asthma, chronic bronchitis or pulmonary emphysema),
arthritis (rheumatoid arthritis or osteoarthritis), cancer, or
any other chronic disease. The accuracy of self-reports of
these diseases was compared to general practitioner infor-
mation, and was shown to be adequate and independent of
cognitive impairment [31]. Use of anti-depressive medica-
tion and benzodiazepines was determined by inspection of
the medication that the participants brought in.
Statistical analyses
Descriptive statistics were used to describe attrition and
its determinants according to depression status at base-
line. Next, diagnoses at 2-years follow-up were described
according to baseline diagnostic status. In addition,
specific course types were described according to the
severity of depressive symptoms obtained from the five
6-monthly assessments with the IDS (see description IDS).
The socio-demographics, clinical and treatment char-
acteristics were described for the depressed patients ac-
cording to their depression diagnoses (MDD, dysthymia
or minor depression) according to DSM-IV-R criteria at
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teristics and the outcome measure depression diagnoses
(y/n) at 2-year follow-up, were first assessed with univariate
logistic regression analyses. Subsequently, when p < 0.10
the variables were entered in a final multivariate model. All
analyses were performed by using SPSS 21.0 (IBM SPSS,
Chicago, IL).Results
Attrition and its determinants
From the 510 persons that were included at baseline,
401 persons participated in the 2-year follow-up assess-
ment (overall attrition rate of 21.4%). Twenty-eight per-
sons died during the two-year follow-up (5.5%). From
the 482 participants who were still available for the study
at that time point, 401 persons (83.4%) participated in
second face-to-face measurement. In the patient group,
the most important reasons for attrition were death (28.0%)
and mental problems (37.6%). In the non-depressed com-
parison group the most important reason for attrition was,
having no interest or no time (50%) (Table 1).
Attrition was significantly higher among persons who
were depressed at baseline, and among those with lower
education, more severe psychopathology and lower cog-
nitive functioning (all p < 0.05). Recruitment area and
sampling frame also differed between respondents and
non-respondents at follow-up. Non-respondents had more
often been recruited in Apeldoorn/Zutphen and Nijmegen
and from outpatient and inpatient mental health facilities
(both p < 0.01).Table 1 Attrition at 2-year follow-up according to depression





N (%) N (%)
Respondents at 2-y follow-up 285 (75.4) 116 (87.9)
Non-respondents at 2-y follow-up 93 (24.6) 16 (12.1)
Reasons of attrition
Deceased 26 (28.0) 2 (12.5)
Refusal
No interest/no time 14 (15.0) 8 (50.0)
Bad experience with previous
interview
1 (1.1) 0 (0)
Unable
Due to physical reasons 12 (12.9) 2 (12.5)
Due to mental reasons 35 (37.6) 4 (25.0)
Noncontact
No contact 4 (4.3) 0 (0)
Moved abroad 1 (1.1) 0 (0)Course of depression
Depression diagnoses at two-year follow-up according to
baseline depression diagnoses are shown in Table 2.
From the 285 persons who were suffering from a depres-
sive disorder at baseline, almost half (48.4%) also suf-
fered from a depressive disorder two years later. About
59% of the persons with a double depression (MDD and
dysthymia) at baseline, also had a depression diagnoses
at 2-year follow-up. From the persons with a MDD at
baseline 44% were also depressed at follow-up. All four
persons with dysthymia only at baseline were also de-
pressed at FU. Among the persons with a minor depres-
sion the highest remission rates were reached (63.6%).
Only 19% of the persons that was depressed at baseline
was completely in remission, with at least the last two IDS
assessments lower than 14, whereas 56% of the persons
with a depressive disorder at baseline, but without a
depressive disorder at follow-up, still had IDS-score
higher than 14, suggesting residual depressive symp-
toms at follow-up.
According to the severity of depressive symptoms as
assessed with the IDS every six months, 61% of the per-
sons that were depressed at baseline had a chronic
(mild/moderate, severe, or variable) course (see Figures 1
and 2), whereas 20% had intermittent depression – with
at least one assessment during the 2-year period without
depressive symptoms (IDS score <14).
Determinants of depressive disorder at 2-year follow-up
Finally, we examined which baseline socio-demographic
and clinical characteristics predicted a depression diag-
noses at 2-year follow-up (Table 3). Univariate analyses
showed that dysthymia, a younger age of onset, higher
IDS score, more chronic diseases and being recruited
from primary care were associated with having a depres-
sive disorder at follow-up. In multivariate regression ana-
lyses, independent associations appeared to be a younger
age of onset, higher IDS score, and having more chronic
diseases at baseline (Table 4).
Discussion
Our study showed that in a sample of clinically de-
pressed older patients nearly 50% still had a depression
diagnoses at 2-year follow-up. Of our patients 61%
showed a chronic course of the depressive symptoms
during the two-year period. Patients with more severe
depressive symptoms, comorbid dysthymia, younger age
of onset and more chronic diseases were more likely to
be depressed at 2-year follow-up.
Our findings are largely in line with expectations from
community based, primary care and other clinical sam-
ples of older persons [6,10,13,15,32]. Consistent with the
findings of Hybels et al. [13], we found that the persons
with a double depression (MDD and dysthymia) had the
Table 2 Depression diagnoses at 2-year follow-up according to baseline diagnoses
N 2 year follow-up
Baseline Double depression1 Major depression Dysthymia Minor depression No depression diagnoses
Double depression1, n (%) 71 20 (28.2) 17 (23.9) 3 (4.2) 2 (2.8) 29 (40.8)
Major depression, n (%) 199 38 (19.1) 36 (18.1) 6 (3.0) 8 (4.0) 111 (55.8)
Dysthymia, n (%) 4 0 1 (25) 3 (75.0) 0 0
Minor depression, n (%) 11 0 1 (9.1) 2 (18.2) 1 (9.1) 7 (63.6)
1Major depression and dysthymia.
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pressive disorder at two years follow-up. Compared to
studies among adults aged 18 to 65 years, our remission
rates seem somewhat lower. In the Netherlands Study
on Depression and Anxiety (NESDA) [18], which has a
comparable design and uses largely the same instru-
ments as in NESDO, about 80% of the purely depressed
patient reached remission within 2 years, whereas from
the persons with a comorbid anxiety disorder only 50%
reached remission within that time frame. In our study,
36.8% of the depressed persons had a comorbid anxiety
disorder, however, comorbidity was no predictor of a de-
pression diagnoses at follow-up. Thus, we may conclude
that our study confirms the poorer prognosis of depres-
sion in terms of chronicity among older persons com-
pared to younger adults.Figure 1 Course of depression (percentages). [Remission: at least
the last two observations IDS score < 14; Intermittent: at least one of
the observations IDS < 14 (not being the last two observations);
Chronic depression, defined as all IDS scores > 14 and sub classified
as: chronic mild to moderate depression, defined as all IDS scores
between 14 and 26; chronic moderate to severe depression, defined
as all IDS scores between 26 and 84; chronic depression with
variable severity, defined as IDS scores varying between 14 to 84].Since we assessed the severity of depressive symptoms
every 6 months, it was possible to study the course of
depression in more detail. Of the depressed patients,
61% showed a chronic course of the depressive symp-
toms during the two years of follow-up, whereas 20%
had intermittent depressive symptoms. These findings
suggest that most patients had clinically relevant levels
of depressive symptoms all the time during this 2-year
period, further stressing the persistence and chronicity
of the depressive symptoms, despite the fact that most
of them were being treated in mental health care facil-
ities. Only 19% of the depressed older people reached
complete remission, whereas 56% of the persons without
a depression diagnoses at follow-up still had residual de-
pressive symptoms.
With respect to the determinants of the prognosis of de-
pression we found that patients with more severe depression
at baseline, comorbid dysthymia, younger age of onset and
more chronic diseases were more likely to be depressed at
2-year follow-up. None of the socio-demographic variables
appeared to be a predictor of the prognosis, neither was
comorbid anxiety disorder or cognitive functioning.Figure 2 Severity of depressive symptoms according to course
during 2-year follow-up. [Remission: at least the last two
observations IDS score < 14; Intermittent: at least one of the
observations IDS < 14 (not being the last two observations); Chronic
depression, defined as all IDS scores > 14 and sub classified as:
chronic mild to moderate depression, defined as all IDS scores
between 14 and 26; chronic moderate to severe depression, defined
as all IDS scores between 26 and 84; chronic depression with
variable severity, defined as IDS scores varying between 14 to 84].
Table 3 Descriptives of patient who were depressed at
baseline according to their depression status at 2-year
follow-up
Not depressed at
follow-up (n = 147)
Depressed at
follow-up (n = 138)
Socio-demographics at
baseline
- Mean age (sd) 70.4 (7.1) 70.9 (7.9)
- Female gender, n (%) 97 (66.0) 90 (65.2)
- Years of education,
mean (sd)
10.7 (3.2) 10.5 (3.7)
- No partner, n (%) 66 (44.9) 72 (52.2)
- Sampling site, n (%)
- Amsterdam 61 (48.8) 64 (51.2)
- Leiden 26 (44.1) 33 (55.9)
- Groningen 22 (55.0) 18 (45.0)
- Apeldoorn/Zutphen 21 (67.7) 10 (32.2)
- Nijmegen 17 (56.7) 13 (43.3)
Clinical characteristics at
baseline
- First episode MDD, n (%) 70 (47.6) 65 (47.1)
- Dysthymia, n (%) 29 (19.7) 46 (33.3)
- Age of onset of
depression, mean (SD)
51.2 (19.5) 44.2 (20.7)
- Comorbid anxiety disorder,
n (%)
48 (32.7) 57 (41.3)
- Severity depression
symptoms
25.6 (11.8) 33.9 (12.5)
Sampling frame, n (%)
- Primary care 17 (40.5) 25 (59.5)
- Ambulant mental health
care
111 (51.9) 103 (48.1)
- Clinical mental health care 19 (65.5) 10 (34.5)
- Use anti depressive
medication, n (%)
106 (72.1) 96 (69.6)
- Use of benzodiazepines,
n (%)
54 (36.7) 57 (41.3)
Comorbidity
- Number of chronic
diseases, mean (sd)
1.8 (1.2) 2.4 (1.7)
- MMSE, mean (sd) 28.0 (1.7) 27.7 (1.8)
MMSE: Mini Mental State Examination.
Table 4 Univariate and multivariate determinants of a
depressive disorder (yes/no) at follow-up in the patient
group (n = 285)
The presence of depression at
2-year follow up
Univariate Multivariate1
OR (95% CI) OR (95% CI)
Socio-demographics
- Age at baseline, in years 1.01 (0.98 – 1.04)
- Female gender 0.97 (0.59 – 1.58)
- Education, in years 0.99 (0.92 – 1.05)
- No partner 1.34 (0.84 – 2.13)
- Sampling site
- Amsterdam Ref group Ref group
- Leiden 1.21 (0.65 – 2.25) 1.63 (0.81-3.29)
- Groningen 0.78 (0.38 – 1.59) 0.95 (0.42-2.11)
- Apeldoorn/Zutphen 0.45 (0.20 – 1.04) 0.56 (0.21-1.53)
- Nijmegen 0.73 (0.33 – 1.63) 0.81 (0.32-2.06)
Clinical characteristics at baseline
- First episode MDD 0.98 (0.62 – 1.56)
- Dysthymia 2.03 (1.19 – 3.49) 1.30 (0.71-2.37)
- Onset of depression, in years 0.98 (0.97 – 0.995) 0.99 (0.98-1.00)
- Comorbid anxiety disorder 1.45 (0.90 – 2.35)
- Severity depression symptoms 1.06 (1.04 – 1.08) 1.05 (1.03-1.07)
Sampling frame
- Primary care Ref group Ref group
- Ambulant mental health care 0.63 (0.32 – 1.24) 0.57 (0.26-1.21)
- Clinical mental health care 0.36 (0.13 – 0.96) 0.43 (0.13-1.42)
- Use anti depressive medication 0.88 (0.53 – 1.47)
- Use of benzodiazepines 1.05 (0.83 – 1.34)
Comorbidity at baseline
- Number of chronic diseases 1.37 (1.16 – 1.63) 1.21 (1.01-1.46)
- MMSE 0.91 (0.80 – 1.04)
1All variables with univariate p < 0.10 included.
MMSE: Mini Mental State Examination.
P-levels < 0.05 are printed bold.
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that reported severity and chronicity of depressive
symptoms [19] and medical comorbidity [21] to be re-
lated with an increased time to recovery. In contrast
with Alexopoulos [19] however, we found an early on-
set of depression to be associated with poor prognosis.
Also in contrast with our results, Bogner [14] showed
in the PROSPECT study that married patients had a
favourable course of depression, suggesting that depressedpersons with a supportive relationship improve more
quickly. In our study, partner status was not statistically
significant. This may be the due to the severity of depres-
sion, our sample was mainly recruited in in- and outpa-
tients facilities, whereas the PROSPECT sample was
recruited in primary care.
Although we included important socio-demographic,
and clinical characteristics as possible determinants for
the prognosis of depression, additional key biological,
health and psychosocial determinants may be of rele-
vance for the prognosis of depression. However, before
conducting such in-depth analyses in the NESDO sample,
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pression and its socio-demographic and clinical determi-
nants, as was the aim of the present paper.
Attrition is an inevitable problem in studies among
vulnerable older persons. We made extensive efforts to
contact and invite persons to participate in the study
and offering them shortened interviews when necessary.
We kept in touch with all participants every half year
and send them yearly newsletters. Nevertheless, the at-
trition at 2-year follow-up was highest in the depressed
group 24.6% compared to 12.1% in the non-depressed
control group. In the depressed group 28% died and
37.6% did not want to participate due to mental reasons.
Unfortunately attrition was selective; attrition was higher
among persons who were depressed at baseline and who
had severe psychopathology, lower cognitive functioning,
and were recruited from outpatient or inpatients mental
health care settings. In the aforementioned comparable
NESDA study among younger adults aged 18–65, the
two-year attrition rate was 12.9% which was relatively
low compared to other epidemiological studies in psy-
chiatric samples and was mainly due to refusal to further
participate [33]. Among older adults, attrition rates are
expected to be higher, because of a higher risk for death
and diseases compared to younger adults. In the Longi-
tudinal Aging Study Amsterdam, a population based cohort
study among older persons age 55 years and older, three-
year attrition rates were around 19% and was mainly due to
death [34]. We may therefore conclude that the attrition rate
in our study is not extremely high, when taking age and dis-
ease status of our sample into account, but it may limit the
generalizability of the findings to some extent and needs to
be reflected upon in future studies.
It should be noted that our findings cannot be general-
ized to community-dwelling older persons, as most of
our patients were recruited from specialized mental
health facilities and may represent a group with more re-
fractory depression at baseline. However, we were espe-
cially interested in this group because patients with
clinical depression are often underrepresented in com-
munity based samples. Thus far, few studies investigated
the naturalistic course of late-life-depression in a large
sample of older persons with formal depression diagno-
ses. Our findings are therefore important for clinical
practice.
Clinical implications
As most of the diagnosed patients (85.3%) were under
treatment when they entered the NESDO study, the re-
sults may tell us something about the adequacy of the
depression treatment in this older age group. Regular in-
terventions are mainly adapted from guidelines that are
based on research performed in younger adults, assuming
that depression in older persons has the same underlyingmechanism as depression in younger adults. Although
pharmacological and psychotherapy are effective treat-
ments for late-life depression [35,36], it is suggested that
antidepressants may be less efficacious in in older de-
pressed patients compared to younger ones [37,38].
Moreover, studies are generally limited to the youngest
old, reflected by average samples ages below 70 years
and minimal physical comorbidity [36].
In older persons, depression treatment may need to be
tailored to address underlying etiological factors and co-
morbidity as well. The group of Alexopoulos [39] devel-
oped a personalized intervention for depressed patients
with severe chronic obstructive pulmonary dysplasia
(COPD) and showed that this intervention reduced de-
pressive symptoms and dyspnea-related disability more
than usual care over 28 weeks. However, thus far there
is only limited evidence that such a multifactorial per-
sonalized treatment is more effective than the regular
treatment. Nevertheless, personalizing depression treat-
ment seems necessary to improve the treatment of depres-
sion, especially in this older age group. Our results suggest
that physical comorbidity may be candidate for adjusted
and intensified treatment strategies of older depressed
patients with chronic and complex pathology.
Conclusions
Our study showed that almost half of a group of older
patients with a depressive disorder were also suffering
from a depressive disorder two years later, and that most
of them had a chronic course of the depressive symp-
toms during the 2 years of follow-up. More serious de-
pression, a younger age of depression onset, and more
somatic comorbidity were independent determinants of
a poor prognosis of depression.
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